Pharmacy is not dying, but it is changing fast enough that the question makes sense. The U.S. Bureau of Labor Statistics projects pharmacist employment to grow 5 percent from 2024 to 2034, faster than the average for all occupations, with roughly 14,200 job openings expected each year. What is shifting, sometimes painfully, is where pharmacists work, what they do, and which corners of the profession are thriving versus struggling.
Retail Pharmacy Is Shrinking
The part of pharmacy most visible to the public, the retail drugstore counter, is the part under the most pressure. Nearly 1 in 3 retail pharmacies in the United States closed between 2010 and 2021, and the pace of closures has more than doubled in recent years. Independent pharmacies have been hit hardest, closing at more than twice the rate of chain pharmacies. The main driver is reimbursement. Pharmacy benefit managers, the intermediaries that negotiate drug prices between insurers and pharmacies, have squeezed profit margins to the point where filling prescriptions is barely profitable for many stores. Mergers between large pharmacy chains and PBMs have made the problem worse, pushing reimbursement rates even lower for independents and rival chains.
Retail pharmacist pay reflects this squeeze. Salaries in retail outpatient settings have slightly declined, dropping about 0.8 percent in recent years while pay in hospitals, physician offices, and other non-retail settings has risen. Total retail pharmacist employment peaked around 189,000 in 2017 and has drifted downward since. If your image of “pharmacy” is someone counting pills behind a CVS counter, then yes, that version of the field is contracting.
Hospital and Clinical Roles Are Growing
The shift away from retail has a flip side. Non-retail pharmacist employment, spanning hospitals, physician offices, outpatient care centers, and home health, grew by nearly 22,000 positions from 2013 to 2020. The share of pharmacists working outside retail rose from 27 percent to 32 percent over that same period, reaching a new high in hospital settings.
Specialty certification tells a similar story. The number of board-certified pharmacy specialists exploded from about 3,000 in 2008 to over 41,800 by 2020, a 13-fold increase. The fastest-growing specialties are critical care and infectious diseases, both expanding at 32 percent, with oncology and ambulatory care also growing rapidly. Projections suggested more than 62,000 specialty certifications by 2025. These roles look nothing like traditional dispensing. Pharmacists in these positions manage complex medication regimens, adjust dosing, and work alongside physicians as part of care teams.
States Are Expanding What Pharmacists Can Do
A wave of state legislation is redefining pharmacists as healthcare providers, not just dispensers. In 2023 alone, Wyoming, Virginia, Maryland, Missouri, and North Dakota all passed laws allowing pharmacists to be reimbursed through Medicaid or commercial insurance for clinical services within their scope of practice. Maryland’s law, one of the broadest, requires both Medicaid and state-regulated commercial plans to recognize pharmacists as providers and reimburse them for all covered services.
This matters because it opens revenue streams that don’t depend on filling prescriptions. Pharmacists billing for comprehensive medication management, chronic disease monitoring, and vaccine administration can build sustainable practices even as dispensing margins collapse. The trend is accelerating. As more states grant provider status, pharmacists gain access to the same billing codes and reimbursement rates as other practitioners, which creates economic incentive for employers to use pharmacists in clinical roles.
Automation Is Changing the Work, Not Eliminating It
Robotic dispensing systems can fill 300 prescriptions in an hour, roughly what a staffed Walgreens pharmacy might process in an entire day. That kind of efficiency naturally raises the question of whether pharmacists will be replaced by machines. The reality so far is that automation handles the mechanical parts of the job (counting, labeling, packaging) while pushing pharmacists toward clinical tasks that require judgment. Checking for drug interactions in a patient taking twelve medications, counseling someone through a complicated treatment plan, or adjusting insulin dosing in a hospital are not tasks a robot performs.
The pharmacies adopting automation generally aren’t laying off their pharmacists. They’re reallocating their time. That said, if the only skill a pharmacist brings is dispensing accuracy, automation does threaten that narrow role.
The Financial Calculus for New Students
For anyone considering pharmacy school, the economics deserve a hard look. The average pharmacist salary sits around $101,600 per year, with the top 10 percent earning about $124,800. Those are solid numbers in isolation, but pharmacy school is expensive. Federal student loan debt for recent PharmD graduates has averaged around $153,000 for those carrying loans, and that figure only includes federal borrowing.
Pharmacy school enrollment is already responding to these pressures. Applications to PharmD programs totaled roughly 36,800 in 2023-24, and the number of degrees awarded dropped from about 12,600 in 2023 to 11,400 in 2024. Fewer graduates entering the pipeline could eventually ease the job market, but anyone starting pharmacy school today should plan for the field they’ll graduate into, not the one that existed a decade ago. That means targeting clinical rotations, pursuing residency training, and considering specialty certification rather than assuming a retail position will be waiting.
Where the Field Is Headed
The pharmacist standing behind a retail counter filling prescriptions all day is a role in decline. The pharmacist embedded in a hospital critical care unit, running a specialty pharmacy for cancer patients, or managing chronic disease in an outpatient clinic is a role in demand. The profession is splitting into two tracks: one that automation and economic pressure are steadily eroding, and one that state legislatures and healthcare systems are actively expanding.
Pharmacy isn’t dying. But the version of it that many people picture when they hear the word is becoming a smaller part of a larger, more clinical profession. For people willing to pursue specialty training and clinical roles, the job market looks healthy. For those expecting to fill prescriptions at a chain drugstore for 30 years with rising pay, the outlook is considerably less promising.